Skip to main content
. 2020 Sep 9;370:m3027. doi: 10.1136/bmj.m3027

Table 1.

Baseline characteristics of adults with chronic midportion Achilles tendinopathy assigned to a high volume injection without corticosteroid or placebo injection. Values are numbers (percentages) unless stated otherwise

Characteristics High volume injection group (n=39) Placebo injection group (n=41)
Mean (SD) age (years) 46.9 (8.1) 48.9 (9.9)
Men 17 (44) 22 (54)
Mean (SD) body mass index 26.8 (5.7) 27.6 (5.1)
Activity level*:
 Active in sports 31 (79) 33 (80)
 Sedentary 8 (21) 8 (20)
Participation in desired sport (total hours per week) 3.9 (2.0) 4.9 (3.6)
Affected side:
 Unilateral, left/right 11/11 (56) 15/15 (73)
 Bilateral 17 (44) 11 (27)
Median (interquartile range) duration of symptoms (weeks) 64 (17-112) 60 (14-107)
Mean (SD) VISA-A score 44.4 (15.5) 41.0 (16.0)
Interventions at study start:
 None 24 (62) 19 (46)
 Night splint 1 (3) 0 (0)
 Foot orthoses 10 (26) 18 (44)
 Pain killers 1 (3) 4 (10)
 Others 3 (8) 1 (2)
Doppler flow:
 Intratendinous 33 (85) 37 (90)
 Peritendinous 6 (15) 4 (10)

VISA-A=Victorian Institute of Sports Assessment-Achilles.

*

Determined using the ankle activity score. Participants who scored ≥4 points were considered to be active in sports (starting from physical work). Participants who scored ≤3 points were considered to be sedentary (cycling, equestrian, or less activity). Level of sport and sports participation is only presented for the active group.